• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PIK3CA 相关淋巴管畸形的基因型与临床严重程度相关。

Genotype correlates with clinical severity in PIK3CA-associated lymphatic malformations.

机构信息

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington, USA.

Division of Pediatric Otolaryngology, Department of Head and Neck Surgery, University of Washington, Seattle, Washington, USA.

出版信息

JCI Insight. 2019 Nov 1;4(21):129884. doi: 10.1172/jci.insight.129884.

DOI:10.1172/jci.insight.129884
PMID:31536475
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6948764/
Abstract

Lymphatic malformations (LMs) are congenital, nonneoplastic vascular malformations associated with postzygotic activating PIK3CA mutations. The mutation spectrum within LMs is narrow, with the majority having 1 of 3 hotspot mutations. Despite this relative genetic homogeneity, clinical presentations differ dramatically. We used molecular inversion probes and droplet digital polymerase chain reaction to perform deep, targeted sequencing of PIK3CA in 271 affected and unaffected tissue samples from 81 individuals with isolated LMs and retrospectively collected clinical data. Pathogenic PIK3CA mutations were identified in affected LM tissue in 64 individuals (79%) with isolated LMs, with variant allele fractions (VAFs) ranging from 0.1% to 13%. Initial analyses revealed no correlation between VAF and phenotype variables. Recognizing that different mutations activate PI3K to varying degrees, we developed a metric, the genotype-adjusted VAF (GVAF), to account for differences in mutation strength, and found significantly higher GVAFs in LMs with more severe clinical characteristics including orofacial location or microcystic structure. In addition to providing insight into LM pathogenesis, we believe GVAF may have broad applicability for genotype-phenotype analyses in mosaic disorders.

摘要

淋巴管畸形(LMs)是一种与合子后激活的 PIK3CA 突变相关的先天性、非肿瘤性血管畸形。LMs 中的突变谱较窄,大多数具有 3 个热点突变之一。尽管存在这种相对的遗传同质性,但临床表现却有很大差异。我们使用分子反转探针和液滴数字聚合酶链反应对 81 名孤立性 LMs 患者的 271 个受累和未受累组织样本进行了 PIK3CA 的深度靶向测序,并回顾性收集了临床数据。在 64 名(79%)孤立性 LMs 患者的受累 LM 组织中发现了致病性 PIK3CA 突变,变异等位基因分数(VAF)范围为 0.1%至 13%。初步分析显示 VAF 与表型变量之间无相关性。鉴于不同的突变以不同的程度激活 PI3K,我们开发了一种衡量标准,即基因型调整的 VAF(GVAF),以考虑突变强度的差异,并发现具有更严重临床特征(包括口面位置或微囊结构)的 LMs 的 GVAF 显著更高。除了为 LM 发病机制提供深入了解外,我们还认为 GVAF 可能在镶嵌性疾病的基因型-表型分析中具有广泛的适用性。

相似文献

1
Genotype correlates with clinical severity in PIK3CA-associated lymphatic malformations.PIK3CA 相关淋巴管畸形的基因型与临床严重程度相关。
JCI Insight. 2019 Nov 1;4(21):129884. doi: 10.1172/jci.insight.129884.
2
Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations.CLOVES 中的非热点 PIK3CA 突变比常见或联合淋巴管畸形更频繁。
Orphanet J Rare Dis. 2021 Jun 10;16(1):267. doi: 10.1186/s13023-021-01898-y.
3
Blockade of VEGF-C signaling inhibits lymphatic malformations driven by oncogenic PIK3CA mutation.阻断 VEGF-C 信号可抑制由致癌性 PIK3CA 突变驱动的淋巴管畸形。
Nat Commun. 2020 Jun 8;11(1):2869. doi: 10.1038/s41467-020-16496-y.
4
Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA.淋巴管及其他血管畸形/过度生长疾病由PIK3CA基因的体细胞突变引起。
J Pediatr. 2015 Apr;166(4):1048-54.e1-5. doi: 10.1016/j.jpeds.2014.12.069. Epub 2015 Feb 11.
5
PIK3CA mutations are specifically localized to lymphatic endothelial cells of lymphatic malformations.PIK3CA 突变特异性定位于淋巴管畸形的淋巴管内皮细胞。
PLoS One. 2018 Jul 9;13(7):e0200343. doi: 10.1371/journal.pone.0200343. eCollection 2018.
6
A somatic mutation in PIK3CD unravels a novel candidate gene for lymphatic malformation.PIK3CD 中的体细胞突变揭示了淋巴管畸形的一个新候选基因。
Orphanet J Rare Dis. 2021 May 8;16(1):208. doi: 10.1186/s13023-021-01782-9.
7
Constitutively active PIK3CA mutations are expressed by lymphatic and vascular endothelial cells in capillary lymphatic venous malformation.毛细血管淋巴管静脉畸形中淋巴管和血管内皮细胞表达组成性激活的 PIK3CA 突变。
Angiogenesis. 2020 Aug;23(3):425-442. doi: 10.1007/s10456-020-09722-0. Epub 2020 Apr 30.
8
-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution.与发育障碍相关的疾病表现出不同类别的突变,其表达和组织分布具有可变性。
JCI Insight. 2016 Jun 16;1(9). doi: 10.1172/jci.insight.87623.
9
Characterization of a severe case of PIK3CA-related overgrowth at autopsy by droplet digital polymerase chain reaction and report of PIK3CA sequencing in 22 patients.通过液滴数字聚合酶链反应对尸检中严重的 PIK3CA 相关过度生长病例进行特征描述,并报告 22 例患者的 PIK3CA 测序结果。
Am J Med Genet A. 2018 Nov;176(11):2301-2308. doi: 10.1002/ajmg.a.40487. Epub 2018 Jul 31.
10
A novel method for isolating lymphatic endothelial cells from lymphatic malformations and detecting PIK3CA somatic mutation in these isolated cells.一种从淋巴管畸形中分离淋巴管内皮细胞并检测这些分离细胞中 PIK3CA 体细胞突变的新方法。
Surg Today. 2021 Mar;51(3):439-446. doi: 10.1007/s00595-020-02122-3. Epub 2020 Sep 2.

引用本文的文献

1
Embryological cellular origins and hypoxia-mediated mechanisms in PIK3CA-driven refractory vascular malformations.PIK3CA驱动的难治性血管畸形的胚胎细胞起源及缺氧介导机制
EMBO Mol Med. 2025 Apr 16. doi: 10.1038/s44321-025-00235-1.
2
Dysfunctional mechanotransduction regulates the progression of PIK3CA-driven vascular malformations.功能失调的机械转导调节PIK3CA驱动的血管畸形的进展。
APL Bioeng. 2025 Feb 5;9(1):016106. doi: 10.1063/5.0234507. eCollection 2025 Mar.
3
Uncovering somatic mosaic variants of -related overgrowth disorders - three cases with different clinical presentations.揭示与过度生长障碍相关的体细胞镶嵌变异——三例不同临床表现的病例
Front Genet. 2025 Jan 13;15:1484651. doi: 10.3389/fgene.2024.1484651. eCollection 2024.
4
Dysfunctional mechanotransduction regulates the progression of PIK3CA-driven vascular malformations.功能失调的机械转导调节PIK3CA驱动的血管畸形的进展。
bioRxiv. 2024 Dec 9:2024.08.22.609165. doi: 10.1101/2024.08.22.609165.
5
A multi-step approach to overcome challenges in the management of head and neck lymphatic malformations, and response to treatment.一种克服头颈部淋巴管畸形管理挑战的多步骤方法,以及对治疗的反应。
Orphanet J Rare Dis. 2024 Jul 23;19(1):276. doi: 10.1186/s13023-024-03200-2.
6
Lymphatic malformations: mechanistic insights and evolving therapeutic frontiers.淋巴管畸形:发病机制的深入理解和不断发展的治疗前沿。
J Clin Invest. 2024 Mar 15;134(6):e172844. doi: 10.1172/JCI172844.
7
The development of early human lymphatic vessels as characterized by lymphatic endothelial markers.早期人类淋巴管的发育特征为淋巴管内皮标志物。
EMBO J. 2024 Mar;43(5):868-885. doi: 10.1038/s44318-024-00045-0. Epub 2024 Feb 14.
8
Updates in Genetic Testing for Head and Neck Vascular Anomalies.头颈部血管异常的基因检测新进展。
Oral Maxillofac Surg Clin North Am. 2024 Feb;36(1):1-17. doi: 10.1016/j.coms.2023.09.001. Epub 2023 Oct 20.
9
Microcystic lymphatic malformations in Turner syndrome are due to somatic mosaicism of PIK3CA.特纳综合征中的微囊型淋巴管畸形是由于 PIK3CA 的体细突变。
Am J Med Genet A. 2024 Jan;194(1):64-69. doi: 10.1002/ajmg.a.63385. Epub 2023 Sep 13.
10
Targeted next-generation sequencing for detection of PIK3CA mutations in archival tissues from patients with Klippel-Trenaunay syndrome in an Asian population : List the full names and institutional addresses for all authors.亚洲人群 Klippel-Trenaunay 综合征患者存档组织中 PIK3CA 突变的靶向二代测序检测:列出所有作者的全名和所属机构地址。
Orphanet J Rare Dis. 2023 Sep 4;18(1):270. doi: 10.1186/s13023-023-02893-1.

本文引用的文献

1
Alpelisib for -Mutated, Hormone Receptor-Positive Advanced Breast Cancer.阿培利司治疗 - 突变型、激素受体阳性晚期乳腺癌。
N Engl J Med. 2019 May 16;380(20):1929-1940. doi: 10.1056/NEJMoa1813904.
2
High prevalence of KRAS/BRAF somatic mutations in brain and spinal cord arteriovenous malformations.脑和脊髓动静脉畸形中 KRAS/BRAF 体细胞突变的高发生率。
Brain. 2019 Jan 1;142(1):23-34. doi: 10.1093/brain/awy307.
3
Pisces: an accurate and versatile variant caller for somatic and germline next-generation sequencing data.双鱼座:用于体细胞和种系下一代测序数据的准确且通用的变异调用程序。
Bioinformatics. 2019 May 1;35(9):1579-1581. doi: 10.1093/bioinformatics/bty849.
4
Cancer-Associated PIK3CA Mutations in Overgrowth Disorders.肿瘤相关 PIK3CA 突变与过度生长疾病。
Trends Mol Med. 2018 Oct;24(10):856-870. doi: 10.1016/j.molmed.2018.08.003. Epub 2018 Sep 6.
5
Gene Expression Differences in Pediatric Lymphatic Malformations: Size Really Matters.小儿淋巴管畸形中的基因表达差异:大小至关重要。
Lymphat Res Biol. 2018 Aug;16(4):347-352. doi: 10.1089/lrb.2017.0064.
6
PIK3CA mutations are specifically localized to lymphatic endothelial cells of lymphatic malformations.PIK3CA 突变特异性定位于淋巴管畸形的淋巴管内皮细胞。
PLoS One. 2018 Jul 9;13(7):e0200343. doi: 10.1371/journal.pone.0200343. eCollection 2018.
7
Treatment of Lymphatic Malformations with the mTOR Inhibitor Sirolimus: A Systematic Review.使用mTOR抑制剂西罗莫司治疗淋巴管畸形:一项系统评价。
Lymphat Res Biol. 2018 Aug;16(4):330-339. doi: 10.1089/lrb.2017.0062. Epub 2018 Jun 20.
8
Targeted therapy in patients with PIK3CA-related overgrowth syndrome.PIK3CA 相关过度生长综合征患者的靶向治疗。
Nature. 2018 Jun;558(7711):540-546. doi: 10.1038/s41586-018-0217-9. Epub 2018 Jun 13.
9
PI3K/mTOR inhibition promotes the regression of experimental vascular malformations driven by PIK3CA-activating mutations.PI3K/mTOR 抑制促进由 PIK3CA 激活突变驱动的实验性血管畸形的消退。
Cell Death Dis. 2018 Jan 19;9(2):45. doi: 10.1038/s41419-017-0064-x.
10
Linkage of Metabolic Defects to Activated PIK3CA Alleles in Endothelial Cells Derived from Lymphatic Malformation.淋巴管畸形来源的内皮细胞中代谢缺陷与激活的PIK3CA等位基因的关联。
Lymphat Res Biol. 2018 Feb;16(1):43-55. doi: 10.1089/lrb.2017.0033. Epub 2018 Jan 18.